Study on the Tolerability and Pharmacokinetics of HX009 in Patients With Advanced Solid Tumors
Clinical trial NCT05731752 · UNKNOWN
Trial details
- NCT number
- NCT05731752
- Sponsor
- Hangzhou Hanx Biopharmaceuticals, Ltd.
- Status
- UNKNOWN
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2020-05-28
- Primary completion
- 2024-12-30
- Enrollment
- 80
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.